Critics question motives for withdrawal of addiction drug

10/12/2012 |

Reckitt Benckiser has announced it would withdraw from the U.S. market its Suboxone tablet opioid-dependence treatment while leaving on the market a newer version that dissolves under the tongue and is sold in individual blister packs. The drugmaker cited high rates of accidental pediatric exposure to the tablets and has gradually raised the price to encourage patients to switch.

View Full Article in: